Decisions about add-on reimbursement for medical devices in France in September 2019

28

Oct 2019

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in September 2019.

One (1) decision was released regarding orthopedic devices:

  • DAC, bioabsorbable hydrogel for orthopedic implants (application for registration, rejected because the provided data do not establish the interest)

Eight (8) decisions were released for cardiovascular devices:

  • iVASCULAR LUMINOR 18 and 35, paclitaxel-eluting balloon (application for registration, approved)
  • COMBO PLUS Stent, coronary stent with sirolimus release (pharmacologically active product) with bioabsorbable matrix coated with anti-CD34 monoclonal antibodies (application for registration, rejected because the provided data do not establish the interest)
  • BIOMONITOR 2-AF, implantable cardiac monitor with remote monitoring (application for registration, approved)
  • COMBO Stent, coronary stent with sirolimus release (pharmacologically active product) with bioabsorbable matrix coated with anti-CD34 monoclonal antibodies (application for registration, rejected because the provided data do not establish the interest)
  • CONFIRM RX model DM3500, implantable cardiac monitor (application for registration, approved)
  • LIFEVEST 4000, portable external cardiac defibrillator (application to change the registration conditions, approved)
  • BIOMIME, coronary stent (stent) coated with sirolimus (pharmacologically active product) (application for registration, rejected because the provided data do not establish the interest)
  • ZENITH Universal Distal Body, stent (application for registration, approved)

NIne (9) decisions were released for other devices:

  • CHORUS, sound processor for cochlear implant system (application for registration, approved)
  • NUCLEUS CI612, CI622, and CI632, cochlear implants (application for registration, approved)
  • POUSSEUR2 PREMIUM, electric motor propulsion device controlled only by the accompanying person (application for registration, approved)
  • VTP SYSTEM FOR TOOKAD, consisting of the TOO-DIFFUSER light-diffusing optical fiber, the TOO-PROBE isotropic rectal probe optical fiber, the TOO-CATH S metal end introducer catheter and the TOO-CATH smooth end introducer catheter (application for registration, rejected because the provided data do not establish the interest)
  • LYRIC3, permanent-wear in-ear hearing aid (application for registration, rejected because the provided data do not establish the interest)
  • TOPCHAIR-S, electric wheelchair climber (renewal of registration, approved)
  • PERISTEEN OBTAL, analog obturator tampon (renewal of registration, approved)
  • INFASOURCE, foodstuff for special medical purposes for oral and enteral nutrition (application for registration, approved)

See the list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

06

Jun 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2023. Twenty-one recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, endocrine, ENT, gastrointestinal, and orthopedic devices, as well as medical aids.

Read more

01

Jun 2023

On May 23, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic setting the tariffs for the medical telemonitoring activities covered by social health insurance in the context of the new framework. The tariffs will differ whether they bring an organizational or clinical (improvement in quality of life, morbidity, or mortality) benefit.

Read more

29

May 2023

On May 17, 2023, the Ministry of Health and Prevention published the 2023-2027 Digital Health Roadmap. The new roadmap specifies the priorities and the projects to be carried out by 2027. One of the key objectives is to support the implementation and extension of telemonitoring to more chronic pathologies.

Read more

26

May 2023

In late May 2023, the Norwegian Directorate of e-Health released an updated version of the Norwegian Laboratory code (NLK) system to be implemented no later than July 1, 2023. A total of 142 new codes were added, 33 codes were terminated, and 122 codes were amended.

Read more

25

May 2023

On May 17, 2023, NHS England issued an updated version of the National Genomic Test Directory for cancer, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Two new codes (test-indication combinations) were introduced.

Read more